Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Enterprise Value (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Enterprise Value for 13 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 41.55% to -$1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 41.55% increase, with the full-year FY2025 number at -$1.2 million, up 41.55% from a year prior.
  • Enterprise Value was -$1.2 million for Q4 2025 at Ekso Bionics Holdings, up from -$2.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.2 million in Q4 2025 to a low of -$49.5 million in Q1 2021.
  • A 5-year average of -$19.4 million and a median of -$11.6 million in 2023 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 481.72% in 2021, then soared 76.85% in 2024.
  • Ekso Bionics Holdings' Enterprise Value stood at -$40.4 million in 2021, then soared by 49.2% to -$20.5 million in 2022, then surged by 57.91% to -$8.6 million in 2023, then skyrocketed by 76.85% to -$2.0 million in 2024, then surged by 41.55% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Enterprise Value are -$1.2 million (Q4 2025), -$2.7 million (Q3 2025), and -$5.2 million (Q2 2025).